From: Drug characteristics derived from kinetic modeling: combined 11C-UCB-J human PET imaging with levetiracetam and brivaracetam occupancy of SV2A
Drug
Dose (mg)
Maximum occupancy (%)
Time to reach maximum occupancy (min)
Time to reach half occupancy (min)
LEV
1500
84 ± 2
277 ± 48
6.8 ± 0.8
BRV
50
63 ± 1
38 ± 10
4.1 ± 0.3
100
81 ± 3
21 ± 14
3.2 ± 0.4
200
92 ± 2
29 ± 15
1.9 ± 0.5